Core A: Determining and targeting mechanisms controlling cancer cell division

核心 A:确定和靶向控制癌细胞分裂的机制

基本信息

  • 批准号:
    10332383
  • 负责人:
  • 金额:
    $ 27.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-25 至 2027-02-28
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Gain-of-function mutations of oncogenes and loss-of-function mutations of tumor suppressor genes drive the initiation and progression of human cancer. These genes also play critical roles in normal development and cellular differentiation. Genetic or epigenetic alterations in the Rb pathway are required for the initiation and progression of most types of human cancer. The three inter-related projects in this program will address major outstanding fundamental questions about the functioning of key proteins in the Rb pathway: Cyclin D-Cdk4/6 oncoproteins that regulate Rb by phosphorylation, the Rb family of tumor suppressors that act as transcriptional regulators, and the E2F family of transcription factors that interact with and are directly regulated by the Rb family proteins and control the transcription of genes important for cell cycle progression. A major goal of this program project is to investigate the Rb pathway using an interdisciplinary approach. The major goal of this Core is to provide an administrative framework to help implement the scientific goals and disseminate the results of the proposed experiments. Specifically, the Administrative Core will have three goals. The first goal will be to promote scientific interactions among the Project Leaders and laboratory members involved in the three main Projects and two Scientific Cores. The second goal will be to provide scientific and financial guidance and oversight, including in conjunction with an Internal Advisory Committee and an External Scientific Advisory Board. The third goal will be to facilitate communication among the members of the Projects and Cores themselves and to the greater scientific community and the public. To achieve these goals, the Leader for this Administrative Core, will work closely with the Leaders of each of the Projects and Scientific Cores. Regular scientific interactions to exchange ideas and results, feedback from members of the internal advisory committee and the external scientific advisory board, and specific metrics to monitor progress, will all be critical to help uncover novel fundamental mechanisms underlying cell cycle progression.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JULIEN SAGE其他文献

JULIEN SAGE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JULIEN SAGE', 18)}}的其他基金

Project 2: To determine the consequences of activating Rb function in cancer cells
项目 2:确定激活癌细胞中 Rb 功能的后果
  • 批准号:
    10597166
  • 财政年份:
    2022
  • 资助金额:
    $ 27.65万
  • 项目类别:
Project 2: To determine the consequences of activating Rb function in cancer cells
项目 2:确定激活癌细胞中 Rb 功能的后果
  • 批准号:
    10332381
  • 财政年份:
    2022
  • 资助金额:
    $ 27.65万
  • 项目类别:
Core A: Determining and targeting mechanisms controlling cancer cell division
核心 A:确定和靶向控制癌细胞分裂的机制
  • 批准号:
    10597192
  • 财政年份:
    2022
  • 资助金额:
    $ 27.65万
  • 项目类别:
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies
研究 SCLC 发展的分子和细胞机制,以确定新的治疗策略
  • 批准号:
    10696254
  • 财政年份:
    2019
  • 资助金额:
    $ 27.65万
  • 项目类别:
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies
研究 SCLC 发展的分子和细胞机制,以确定新的治疗策略
  • 批准号:
    10463652
  • 财政年份:
    2019
  • 资助金额:
    $ 27.65万
  • 项目类别:
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies
研究 SCLC 发展的分子和细胞机制,以确定新的治疗策略
  • 批准号:
    10013140
  • 财政年份:
    2019
  • 资助金额:
    $ 27.65万
  • 项目类别:
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies
研究 SCLC 发展的分子和细胞机制,以确定新的治疗策略
  • 批准号:
    9814560
  • 财政年份:
    2019
  • 资助金额:
    $ 27.65万
  • 项目类别:
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies
研究 SCLC 发展的分子和细胞机制,以确定新的治疗策略
  • 批准号:
    10238088
  • 财政年份:
    2019
  • 资助金额:
    $ 27.65万
  • 项目类别:
Notch signaling in small cell lung carcinoma
小细胞肺癌中的Notch信号传导
  • 批准号:
    9122074
  • 财政年份:
    2016
  • 资助金额:
    $ 27.65万
  • 项目类别:
Molecular and cellular mechanisms of SCLC metastasis
SCLC转移的分子和细胞机制
  • 批准号:
    9353182
  • 财政年份:
    2016
  • 资助金额:
    $ 27.65万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 27.65万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 27.65万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 27.65万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 27.65万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 27.65万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 27.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了